The Pentose Phosphate Pathway (PPP), also known as the Hexose Monophosphate Shunt (HMP Shunt), is an alternative metabolic route for glucose metabolism that runs parallel to glycolysis. The HMP pathway is also known as the Warburg-Dickens pathway. About 10% of glucose entering this pathway per day. The liver & RBCs metabolise about 30% of glucose by this pathway.
Unlike glycolysis, its primary purpose is not to generate ATP. Instead, its main functions are:
Think of the PPP as a "shunt" because it diverts glucose-6-phosphate away from glycolysis to serve these distinct purposes, and can then feed intermediates back into glycolysis. It primarily occurs in the cytosol of cells.
The Pentose Phosphate Pathway is divided into two distinct phases:
The PPP is critically important because it provides two essential molecules:
This phase consists of three main reactions, starting with glucose-6-phosphate and culminating in the production of NADPH and ribulose-5-phosphate.
The oxidative phase involves the following sequential reactions:
Glucose-6-phosphate + NADP⁺ → 6-Phosphogluconolactone + NADPH + H⁺6-Phosphogluconolactone + H₂O → 6-Phosphogluconate6-Phosphogluconate + NADP⁺ → Ribulose-5-phosphate + NADPH + H⁺ + CO₂The net reaction for the oxidative phase is:
The non-oxidative phase is a series of reversible reactions that interconvert various sugar phosphates. Its primary functions are:
This phase involves three main enzymes: an isomerase, an epimerase, and two transketolases/transaldolases.
The ribulose-5-phosphate generated in the oxidative phase needs to be converted into other pentose sugars.
Ribulose-5-phosphate ⇌ Ribose-5-phosphateRibulose-5-phosphate ⇌ Xylulose-5-phosphateThese two enzymes are responsible for moving two-carbon and three-carbon units between sugar phosphates to produce glycolytic intermediates.
If 3 molecules of glucose-6-phosphate enter the oxidative phase, they produce 3 molecules of ribulose-5-phosphate and 6 NADPH. These 3 molecules of ribulose-5-phosphate are then processed through the non-oxidative phase:
These glycolytic intermediates can then enter glycolysis, be used for gluconeogenesis, or be recycled to continue the PPP.
The reversibility of the non-oxidative phase is key, allowing the pathway to operate in different modes:
The activity of the PPP varies significantly among different tissues, directly reflecting their metabolic demands for its key products: NADPH and ribose-5-phosphate.
The liver is a central metabolic hub with a high demand for NADPH for:
Adipocytes are specialized for fat storage and have a very high demand for NADPH to support the massive amount of fatty acid synthesis that occurs here.
RBCs lack mitochondria and are constantly exposed to oxidative stress. The PPP is their only source of NADPH for antioxidant defense, used to maintain reduced glutathione (GSH) and protect the cell.
Tissues like the adrenal cortex, testes, and ovaries are primary sites of steroid hormone synthesis and have a high demand for NADPH for these hydroxylation reactions.
During lactation, the mammary gland synthesizes large amounts of fatty acids for milk production, requiring a high supply of NADPH.
Tissues like bone marrow, skin, intestinal mucosa, and tumors are continuously proliferating and require constant DNA and RNA synthesis. They have a high demand for ribose-5-phosphate for nucleotide synthesis.
The non-oxidative phase can be reversed in these cells to primarily produce ribose-5-phosphate from glycolytic intermediates.
The regulation of the Pentose Phosphate Pathway primarily occurs at its committed and rate-limiting step, catalyzed by Glucose-6-Phosphate Dehydrogenase (G6PD). The non-oxidative phase is primarily driven by substrate availability.
G6PD is the most important regulatory enzyme of the PPP. Its activity is controlled by:
Higher levels of G6P generally lead to increased G6PD activity.
The synthesis of G6PD can be regulated at the gene expression level. For example, a high-carbohydrate diet and insulin can lead to an increase in the synthesis of G6PD, increasing the capacity to produce NADPH for fatty acid synthesis.
The reversible reactions are primarily regulated by the availability of substrates and the cell's demand for products.
The PPP and glycolysis compete for the common substrate, glucose-6-phosphate.
NADPH, produced almost exclusively by the PPP, plays essential roles in maintaining cellular homeostasis and facilitating various metabolic processes.
NADPH provides the electrons (reducing power) necessary for many synthetic (anabolic) reactions. Key examples include:
NADPH is crucial for protecting cells from damage by Reactive Oxygen Species (ROS). It maintains the cellular defense system through its role in the glutathione system.
GSSG + NADPH + H⁺ → 2 GSH + NADP⁺2 GSH + H₂O₂ → GSSG + 2 H₂OIn phagocytic immune cells (e.g., neutrophils), NADPH plays a critical role in the "respiratory burst."
NADPH Oxidase: This enzyme uses NADPH to produce superoxide radicals (O₂•⁻), which are then converted into other potent oxidants (like hydrogen peroxide) to kill engulfed bacteria and pathogens.
O₂ + NADPH → O₂•⁻ + NADP⁺ + H⁺The HMP Shunt holds paramount significance due to its unique role in generating two crucial products: pentoses and NADPH. Unlike glycolysis, its value lies in providing essential building blocks and reducing power for various anabolic and protective processes.
The HMP shunt converts hexoses into pentose sugars, with ribose-5-phosphate being the most important. These are indispensable for:
NADPH is a versatile reducing agent, distinct from NADH, and serves as a critical source of electrons for a wide array of anabolic and protective cellular functions.
NADPH provides reducing power for building complex molecules like fatty acids, cholesterol, steroid hormones, and amino acids.
NADPH is critical for regenerating reduced glutathione (GSH), which is used by glutathione peroxidase to neutralize harmful free radicals and peroxides, protecting cells from oxidative damage.
In red blood cells, the concerted action of NADPH and the glutathione system is vital for preserving the integrity of the cell membrane, protecting it from oxidative damage and preventing premature lysis (hemolytic anemia).
NADPH-dependent reductase systems are essential for keeping the iron within hemoglobin in its reduced (ferrous, Fe²⁺) state. This prevents the formation of met-hemoglobin (Fe³⁺), which cannot carry oxygen.
The liver's microsomal cytochrome P450 monooxygenase system depends on NADPH to detoxify drugs and foreign substances by increasing their solubility for excretion.
The eye's lens has a high concentration of NADPH, which is vital for protecting lens proteins from oxidative damage, thereby guarding against conditions like cataracts.
In phagocytic cells, NADPH oxidase uses NADPH to generate large quantities of superoxide radicals in a process called the "respiratory burst." These reactive oxygen species are potent antimicrobial agents used to kill ingested bacteria.
Test your knowledge with these 35 questions.
Question 1/35
Here are your results, .
Your Score
33/35
94%